- Home
- RLAY vs AMN Comparison
RLAY vs AMN Comparison
Compare RLAY & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- AMN
- Stock Information
- Founded
- RLAY 2015
- AMN 1985
- Country
- RLAY United States
- AMN United States
- Employees
- RLAY N/A
- AMN N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- AMN Assisted Living Services
- Sector
- RLAY Health Care
- AMN Health Care
- Exchange
- RLAY Nasdaq
- AMN Nasdaq
- Market Cap
- RLAY 610.3M
- AMN 657.8M
- IPO Year
- RLAY 2020
- AMN 2001
- Fundamental
- Price
- RLAY $3.54
- AMN $18.92
- Analyst Decision
- RLAY Strong Buy
- AMN Hold
- Analyst Count
- RLAY 12
- AMN 8
- Target Price
- RLAY $18.45
- AMN $28.25
- AVG Volume (30 Days)
- RLAY 2.8M
- AMN 1.0M
- Earning Date
- RLAY 08-07-2025
- AMN 08-07-2025
- Dividend Yield
- RLAY N/A
- AMN N/A
- EPS Growth
- RLAY N/A
- AMN N/A
- EPS
- RLAY N/A
- AMN N/A
- Revenue
- RLAY $8,355,000.00
- AMN $2,769,926,000.00
- Revenue This Year
- RLAY $17.59
- AMN N/A
- Revenue Next Year
- RLAY N/A
- AMN $1.95
- P/E Ratio
- RLAY N/A
- AMN N/A
- Revenue Growth
- RLAY N/A
- AMN N/A
- 52 Week Low
- RLAY $1.78
- AMN $14.87
- 52 Week High
- RLAY $10.72
- AMN $54.01
- Technical
- Relative Strength Index (RSI)
- RLAY 52.25
- AMN 50.47
- Support Level
- RLAY $3.31
- AMN $14.87
- Resistance Level
- RLAY $3.61
- AMN $18.91
- Average True Range (ATR)
- RLAY 0.21
- AMN 1.02
- MACD
- RLAY -0.02
- AMN 0.19
- Stochastic Oscillator
- RLAY 68.67
- AMN 83.68
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About AMN AMN Healthcare Services Inc
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.